repinotan hydrochloride has been researched along with Acute Brain Injuries in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lutsep, HL | 1 |
| Horváth, E; Mauler, F | 1 |
| Beckermann, B; Buehner, K; Mauler, F; Schuhmacher, J; Schwarz, T; Seidel, D; Steinke, W; Weinz, C; Zimmerd, D | 1 |
| Heinig, R; Higuchi, S; Kuroki, Y; Tanigawa, T | 1 |
| Dixon, CE; Horváth, E; Kline, AE; Marion, DW; Yu, J | 1 |
| Braakman, R; Legout, V; Ohman, J | 1 |
1 review(s) available for repinotan hydrochloride and Acute Brain Injuries
| Article | Year |
|---|---|
Repinotan Bayer.
Topics: Animals; Benzopyrans; Brain Injuries; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Lethal Dose 50; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Stroke; Structure-Activity Relationship; Thiazoles | 2002 |
2 trial(s) available for repinotan hydrochloride and Acute Brain Injuries
| Article | Year |
|---|---|
Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach.
Topics: Adult; Aged; Asian People; Benzopyrans; Body Weight; Brain Injuries; Ethnicity; Female; Humans; Male; Middle Aged; Models, Statistical; Population; Serotonin Receptor Agonists; Sex Characteristics; Thiazoles; White People | 2006 |
Repinotan (BAY x 3702): a 5HT1A agonist in traumatically brain injured patients.
Topics: Adolescent; Adult; Aged; Benzopyrans; Blood Pressure; Brain Injuries; Double-Blind Method; Female; Humans; Male; Middle Aged; Patients; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Thiazoles; Treatment Outcome | 2001 |
3 other study(ies) available for repinotan hydrochloride and Acute Brain Injuries
| Article | Year |
|---|---|
Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.
Topics: Animals; Benzopyrans; Biomarkers; Brain; Brain Injuries; Hematoma, Subdural, Acute; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Stroke; Succinate Dehydrogenase; Thiazoles | 2005 |
Pharmacokinetics of repinotan in healthy and brain injured animals.
Topics: Animals; Benzopyrans; Blood-Brain Barrier; Brain; Brain Injuries; Male; Rats; Rats, Wistar; Serotonin Receptor Agonists; Thiazoles | 2005 |
The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats.
Topics: Animals; Benzopyrans; Body Temperature; Brain; Brain Injuries; Cognition; Cognition Disorders; Dizocilpine Maleate; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Hippocampus; Male; Maze Learning; Nerve Degeneration; Neurons; Neuroprotective Agents; Postural Balance; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Thiazoles; Vestibular Nuclei | 2001 |